Suzanne Paz

Suzanne Paz

Auto-generated profile, based on publicly available information

Suzanne Paz

Terry Fox Molecular Oncology Group, Lady Davis Institute for Medical Research, McGill University, Montreal, Canada

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2011 in Current Opinion in Immunology
Verified
Journal Article
Closed access
SBS Mehdi Belgnaoui
S Mehdi Belgnaoui
SPSuzanne Paz
Suzanne Paz
JHJohn Hiscott
John Hiscott

30 October 2006 in Oncogene
Verified
Journal Article
Closed access
JHJ Hiscott
J Hiscott
TNT-L A Nguyen
T-L A Nguyen
MAM Arguello
M Arguello
PNP Nakhaei
P Nakhaei
SPS Paz
S Paz

15 June 2006 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
RLRongtuan Lin
Rongtuan Lin
JLJudith Lacoste
Judith Lacoste
PNPeyman Nakhaei
Peyman Nakhaei
QSQiang Sun
Qiang Sun
LYLong Yang
Long Yang
JHJohn Hiscott
John Hiscott
Intracellular RNA virus infection is detected by the cytoplasmic RNA helicase RIG-I that plays an essential role in signaling to the host antiviral response. Recently, the adapter molecule that links RIG-I sensing of incoming viral RNA to downstream signaling and gene activation events was characterized by four different groups; MAVS/IPS-1-1/VISA/Cardif contains an amino-terminal CARD domain and a carboxyl-terminal mitochondrial transmembrane sequence that localizes to the mitochondrial membrane. Furthermore, the hepatitis C virus NS3-4A protease complex specifically targets MAVS/IPS-1/VISA/Cardif for cleavage as part of its immune evasion strategy. With a novel search program written in python, we also identified an uncharacterized protein, KIAA1271 (K1271), containing a single CARD-like domain at the N terminus and a Leu-Val-rich C terminus that is identical to that of MAVS/IPS-1/VISA/Cardif. Using a combination of biochemical analysis, subcellular fractionation, and confocal microscopy, we now demonstrate that NS3-4A cleavage of MAVS/IPS-1/VISA/Cardif/K1271 results in its dissociation from the mitochondrial membrane and disrupts signaling to the antiviral immune response. Furthermore, virus-induced IKKε kinase, but not TBK1, colocalized strongly with MAVS at the mitochondrial membrane, and the localization of both molecules was disrupted by NS3-4A expression. Mutation of the critical cysteine 508 to alanine was sufficient to maintain mitochondrial localization of MAVS/IPS-1/VISA/Cardif and IKKε in the presence of NS3-4A. These observations provide an outline of the mechanism by which hepatitis C virus evades the interferon antiviral response.

4 January 2011 in Cell Research
Verified
Journal Article
Closed access
SPSuzanne Paz
Suzanne Paz
MVMyriam Vilasco
Myriam Vilasco
SWSteven J Werden
Steven J Werden
MAMeztli Arguello
Meztli Arguello
DJDeshanthe Joseph-Pillai
Deshanthe Joseph-Pillai
JHJohn Hiscott
John Hiscott

1 February 2006 in Trends in Molecular Medicine
Verified
Journal Article
Closed access
JHJohn Hiscott
John Hiscott
RLRongtuan Lin
Rongtuan Lin
PNPeyman Nakhaei
Peyman Nakhaei
SPSuzanne Paz
Suzanne Paz

1 August 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
DVDamien Vitour
Damien Vitour
SDStéphanie Dabo
Stéphanie Dabo
MPMalek Ahmadi Pour
Malek Ahmadi Pour
MVMyriam Vilasco
Myriam Vilasco
Pierre-Olivier VidalainPierre-Olivier Vidalain
Pierre-Olivier Vidalain
EMEliane F. Meurs
Eliane F. Meurs
The mitochondria-bound adapter MAVS participates in IFN induction by recruitment of downstream partners such as members of the TRAF family, leading to activation of NF-kappaB, and the IRF3 pathways. A yeast two-hybrid search for MAVS-interacting proteins yielded the Polo-box domain (PBD) of the mitotic Polo-like kinase PLK1. We showed that PBD associates with two different domains of MAVS in both dependent and independent phosphorylation events. The phosphodependent association requires the phosphopeptide binding ability of PBD. It takes place downstream of the proline-rich domain of MAVS, within an STP motif, characteristic of the binding of PLK1 to its targets, where the central Thr234 residue is phosphorylated. Its phosphoindependent association takes place at the C terminus of MAVS. PLK1 strongly inhibits the ability of MAVS to activate the IRF3 and NF-kappaB pathways and to induce IFN. Reciprocally, depletion of PLK1 can increase IFN induction in response to RIG-I/SeV or RIG-I/poly(I)-poly(C) treatments. This inhibition is dependent on the phosphoindependent association of PBD at the C terminus of MAVS where it disrupts the association of MAVS with its downstream partner TRAF3. IFN induction was strongly inhibited in cells arrested in G2/M by nocodazole, which provokes increased expression of endogenous PLK1. Interestingly, depletion of PLK1 from these nocodazole-treated cells could restore, at least partially, IFN induction. Altogether, these data demonstrate a new function for PLK1 as a regulator of IFN induction and provide the basis for the development of inhibitors preventing the PLK1/MAVS association to sustain innate immunity.